Delivery Order SPE2DB22D2206-SPE2DB25FEB60

Award Date 11/4/24
Potential Completion Date 11/5/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEB60
    Delivery Order

This federal contract award, with an award ID of SPE2DB22D2206 and SPE2DB25FEB60, is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The $21,493.29 firm-fixed-price delivery order has a completion date of November 5, 2024 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting vehicles enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/3/25, 1:27 PM